International market

 > Products

Products for the international market



Hospital Market
Molecule Dosage Reference product
Acyclovir
Lyophilised powder for injection
250 mg Zovirax®
(Glaxo SmithKline)
Amikacin
Solution for injection
62,5 mg/ml, 125 mg/ml, 250 mg/ml Amikin®
(Bristol Myers Squibb)
Amoxycillin + clavulanic acid
Powder for injection
500 mg/50 mg, 1 g/200 mg, 2 g/200 mg Augmentin®
(Glaxo SmithKline)
Amphotericin B (Desoxycholate complex)
Lyophilised powder for injection
50 mg Fungizone Intravenous®
(Bristol Myers Squibb)
Cefonicid
Powder and solvent for injection
500 mg, 1 g Monocid®
(Glaxo SmithKline)
Cefotaxime
Powder and solvent for injection
Powder for infusion
500 mg, 1 g
2 g
Claforan®
(Aventis Pharma)
Ceftazidime
Powder for injection
Powder for infusion
500 mg, 1 g
1 g, 2 g
Fortum®
(Glaxo SmithKline)
Ceftriaxone
Powder and solvent for injection
Powder for infusion
250 mg, 500 mg, 1 g
2 g
Rocephin®
(Roche)
Cefuroxime (Sodium)
Powder for injection
Powder for infusion
250 mg, 750 mg
1500 mg
Zinacef®
(Glaxo SmithKline)
Clindamycin
Solution for injection
150 mg/ml (300 mg/2 ml, 600 mg/4 ml, 900 mg/6 ml) Dalacin®
(Pharmacia&Upjohn)
Cloxacillin
Powder for injection
500 mg, 1 g Orbenin®
(Glaxo SmithKline)
Fluconazol
Solution for injection
2 mg/ml (50 ml, 100 ml) Diflucan®
(Pfizer)
Flumazenil
Solution for injection
0,1 mg/ ml (5 ml, 10ml) Anexate®
(Roche)
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007

Hospital Market
Molecule Dosage Reference product
Granisetron
Solution for injection

3 mg/3 ml
Kytril®
(Roche)
Iron sucrose
Solution for injection/concentrate solution for infusion
20 mg/ml Venofer®
(Vifor)
Ketorolac Tromethamine
Solution for injection

30 mg/ml
Toradol®
(Roche)
Levofloxacin
Solution for injection
5 mg/ml (500 mg/100 ml) Tavanic®
(Aventis)
Midazolam
Solution for injection
1 mg/ml (5 mg/5 ml), 5 mg/ml (15 mg/3 ml and 50 mg/10 ml) Hypnovel®
(Roche)
Pamidronate
Lyophilised powder for injection
15 mg, 30 mg, 60 mg, 90 mg Aredia®
(Novartis)
Pantoprazole
Lyophilised powder for injection
40 mg Pantocarm®, Pantoloc®
(Altana Pharma)
Pentamidine
Lyophilised powder for injection
Lyophilised powder for nebuliser solution
300 mg
300 mg
Pentacarinat®
(JHC Healthcare)
Phenytoin
Solution for injection
100 mg/2 ml
250 mg/5 ml
Phenytoin®
(Pfizer/ Rubió)
Piperacillin/Tazobactam
Lyophilised powder for injection
2 g/0,25 g, 4 g/0,5 g Tazobac®
(Wyeth)
Somatostatin
Lyophilised powder for injection
0,25 mg, 3 mg Stilamin® (Serono, IT, NL, CH.)
Aminopanc® (UCB, DE.)
Modustatine® (Clin Midy, FR.)
Teicoplanin
Lyophilised powder for injection
200 mg, 400 mg Targocid®
(Aventis Pharma)
Vancomycin
Lyophilised powder for injection
500 mg, 1 g Vancocin®
(Lilly)
Zidovudine
Capsule
Oral solution
Tablets
100 mg, 250 mg, 300 mg
50 mg/5 ml
300 mg
Retrovir®
(Glaxo SmithKline)
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007

Retail Market (Wholesalers and Pharmacies)
Molecule Dosage Reference product
Acyclovir
Cream
Tablets

5 %
800 mg
Zovirax®
(Glaxo SmithKline)
Doxazosin
Tablets
2 mg, 4 mg Cardura®
(Pfizer)
Fluoxetine
Capsules

20 mg
Prozac®
(Lilly)
Gabapentin
Tablets
Capsules

600 mg, 800 mg
100 mg, 300 mg, 400 mg
Neurontin®
(Pfizer)
Glimepiride
Tablets
1 mg, 2 mg, 3 mg, 4 mg and 6 mg Amaryl®
(Aventis Pharma)
Ibuprofen-lysine
Oral powder for solution
600 mg, 400 mg Algidrin®
(Fardi)
Mirtazapine
Tablets
15 mg, 30 mg, 45 mg Rexer®
(Organon)
Pantoprazole
Tablets, delayed release
20 mg, 40 mg Pantozol®
(Altana Pharma)
Glucosamine Sulphate
Oral powder for solution
1500 mg Xicil®
(Rottapharm)
Venlafaxine
IR Tablets
37,5 mg, 50 mg, 75 mg Effexor®
(Wyeth)
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007